Restricted Access

The information contained on the following web pages is intended exclusively for Swiss residents who are physically located in Switzerland. The following information does not contain or constitute an offer to sell or a solicitation of any offer to buy securities in the United States of America or in any other jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make an offer or solicitation. Users of this website are requested to inform themselves about and to observe any restrictions. The securities of Evolva Holding SA have not been and will not be registered under the United States securities laws and may not be offered or sold in the United States or to or for the account or the benefit of “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the Securities Act)) absent registration or an exemption from registration under the Securities Act. Neither Evolva Holding SA nor its shareholders intend to register any portion of the intended private placement in the United States or conduct a public offering of securities in the United States. The information contained on the following web pages may not be distributed outside of Switzerland or into or within the United States. This communication is only being distributed to and is only directed at persons who are outside the United Kingdom (U.K.) (all such persons together being referred to as relevant persons). Any person who is not a relevant person should not act or rely on the following web pages or any of their contents. Evolva Holding SA securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons and certain other persons to whom it may lawfully be communicated. Some of the information published on this website contains forward-looking statements. Users are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Evolva Holding SA undertakes no obligation to update or revise any information or opinions published on the website. Evolva Holding SA reserves the right to amend the information at any time without prior notice. Securities of Evolva Holding SA described in the information on this website are not being offered publicly, but only to qualified investors in private placements, all in accordance with applicable securities laws in the respective jurisdictions. The information contained on this website may not be considered as being a substitute for economic, legal, tax or other advice and users are cautioned not to base investment decisions or other decisions solely on the content of this website. Users must consult their investment advisers or other advisers prior to making any investment decisions. For legal reasons, the following information is intended exclusively for Swiss residents who are physically located in Switzerland.

The information you provide will only be used for validation purposes and will not be provided to third parties.

Please confirm that you have read the complete legend and accept its terms:

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com